BR0102604A - Solução de sal monossódico da n-[o-(p-pivaloiloxibenzenossul-fonilamino) benzoil] glicina tetrahidratado e produto de droga do mesmo - Google Patents

Solução de sal monossódico da n-[o-(p-pivaloiloxibenzenossul-fonilamino) benzoil] glicina tetrahidratado e produto de droga do mesmo

Info

Publication number
BR0102604A
BR0102604A BR0102604-6A BR0102604A BR0102604A BR 0102604 A BR0102604 A BR 0102604A BR 0102604 A BR0102604 A BR 0102604A BR 0102604 A BR0102604 A BR 0102604A
Authority
BR
Brazil
Prior art keywords
tetrahydrate
benzoyl
glycine
drug product
monosodium salt
Prior art date
Application number
BR0102604-6A
Other languages
English (en)
Other versions
BR0102604B1 (pt
Inventor
Akira Takada
Masao Sudoh
Original Assignee
Ono Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co filed Critical Ono Pharmaceutical Co
Publication of BR0102604A publication Critical patent/BR0102604A/pt
Publication of BR0102604B1 publication Critical patent/BR0102604B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/37—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C07C311/38—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton
    • C07C311/44—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Patente de Invenção: "SOLUçãO DE SAL MONOSSóDICO DA N-[O-(p-PIVALOILOXIBENZENOSSULFONILAMINO)BENZOIL]GLI CINA TETRAHIDRATADO E PRODUTO DE DROGA DO MESMO". Uma solução de sal monossódico da N-[o-(p-pivaloiloxibenzenossulfonilamino) benzoil] glicina tetrahidratado de fórmula (1) que compreende pelo menos um agente de ajuste de pH selecionado entre fosfato trissódico, um hidrato do mesmo, hidróxido de sódio ou hidróxido de potássio.
BRPI0102604-6A 2000-06-29 2001-06-28 composição farmacêutica compreendendo sal monossódico da n-[o- (p-pivaloiloxibenzenossulfonilamino) benzoil] glicina tetrahidratado e uso da mesma. BR0102604B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000195853 2000-06-29
JP2000195852 2000-06-29

Publications (2)

Publication Number Publication Date
BR0102604A true BR0102604A (pt) 2002-02-13
BR0102604B1 BR0102604B1 (pt) 2012-06-26

Family

ID=26594951

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0102604-6A BR0102604B1 (pt) 2000-06-29 2001-06-28 composição farmacêutica compreendendo sal monossódico da n-[o- (p-pivaloiloxibenzenossulfonilamino) benzoil] glicina tetrahidratado e uso da mesma.

Country Status (19)

Country Link
US (1) US6552082B2 (pt)
EP (1) EP1166773B1 (pt)
KR (1) KR100725076B1 (pt)
CN (1) CN1263736C (pt)
AT (1) ATE259218T1 (pt)
AU (1) AU782838B2 (pt)
BR (1) BR0102604B1 (pt)
CA (1) CA2351273C (pt)
DE (1) DE60101979T2 (pt)
DK (1) DK1166773T3 (pt)
ES (1) ES2215856T3 (pt)
HU (1) HUP0102699A2 (pt)
MX (1) MXPA01006698A (pt)
NO (1) NO330296B1 (pt)
NZ (1) NZ512486A (pt)
PT (1) PT1166773E (pt)
RU (1) RU2272623C2 (pt)
TR (1) TR200400585T4 (pt)
TW (1) TWI246925B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002224526A1 (en) * 2000-07-24 2002-02-05 Ono Pharmaceutical Co. Ltd. Freeze-dried preparation of n-(o-(p-pivaloyloxybenzenesulfonylamino)benzoyl)glycine monosodium salt tetrahydrate and process for producing the same
JPWO2002092074A1 (ja) * 2001-05-17 2004-08-26 小野薬品工業株式会社 脊髄障害による疾患治療剤
TW200519080A (en) * 2003-10-03 2005-06-16 Ono Pharmaceutical Co Agent containinf (2R)-2-propyloctanic acid as effective component
US8277845B2 (en) 2007-12-04 2012-10-02 Remedy Pharmaceuticals, Inc. Formulations and methods for lyophilization and lyophilates provided thereby
KR101247137B1 (ko) * 2011-03-23 2013-04-01 주식회사 엠씨켐 Ｎ-[ｏ-(ｐ-피발로일옥시벤젠술포닐아미노)벤조일]글리신의 신규 제조 방법 및 그 모노나트륨염ㆍ4 수화물의 동결 건조 제제의 제조 방법
KR101366706B1 (ko) 2012-12-06 2014-02-24 상명대학교서울산학협력단 Ｎ-[ｏ-(ｐ-피발로일옥시벤젠술포닐아미노)벤조일]글리신의 신규 제조 방법 및 그 모노나트륨염ㆍ4 수화물의 동결 건조 제제의 제조 방법
CN104107172B (zh) * 2013-04-18 2017-11-28 上海汇伦生命科技有限公司 西维来司钠注射用冻干粉的制备方法
CN114681435A (zh) * 2020-12-31 2022-07-01 上海汇伦生物科技有限公司 吸入用药物组合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1340191C (en) 1988-06-13 1998-12-15 Katsuhiro Imaki Derivatives of p-substituted phenyl ester of pivalic acid
JPH0320253A (ja) 1988-06-13 1991-01-29 Ono Pharmaceut Co Ltd ピバル酸　ｐ―置換フェニルエステル誘導体、それらの製造方法およびそれらを有効成分として含有するエラスターゼ阻害剤
IT1242642B (it) * 1990-04-17 1994-05-16 Alfa Wassermann Spa Formulazioni iniettabili contenenti naproxen sale sodico.
JP3020253B2 (ja) 1990-05-02 2000-03-15 松下電工株式会社 配線器具の取付枠への取付構造
JPH05194366A (ja) 1991-10-25 1993-08-03 Ono Pharmaceut Co Ltd グリシン誘導体・モノナトリウム塩・４水和物、その製造方法、それを含有する薬剤および該誘導体の中間体の製造方法
EP0539223A1 (en) 1991-10-25 1993-04-28 Ono Pharmaceutical Co., Ltd. Glycine derivative monosodium salt tetrahydrate having an inhibitory effect on elastase
JP3193597B2 (ja) 1995-07-28 2001-07-30 小野薬品工業株式会社 グリシン誘導体の製造方法
AU5528299A (en) 1998-09-15 2000-04-03 Naeja Pharmaceutical Inc. Combined therapy for treatment of inflammation using elastase inhibitor(s) and antibacterial agent(s)
BR0013793A (pt) * 1999-09-06 2002-05-14 Ono Pharmaceutical Co Medicamentos profiláticos e terapêuticos para doenças oftálmicas

Also Published As

Publication number Publication date
NO20013223D0 (no) 2001-06-27
ES2215856T3 (es) 2004-10-16
TWI246925B (en) 2006-01-11
US20020022738A1 (en) 2002-02-21
CA2351273A1 (en) 2001-12-29
DE60101979T2 (de) 2005-01-05
HU0102699D0 (en) 2001-08-28
EP1166773B1 (en) 2004-02-11
EP1166773A1 (en) 2002-01-02
BR0102604B1 (pt) 2012-06-26
KR100725076B1 (ko) 2007-06-08
CA2351273C (en) 2010-09-07
NZ512486A (en) 2001-12-21
CN1263736C (zh) 2006-07-12
US6552082B2 (en) 2003-04-22
NO20013223L (no) 2001-12-31
RU2272623C2 (ru) 2006-03-27
KR20020002242A (ko) 2002-01-09
MXPA01006698A (es) 2004-07-30
ATE259218T1 (de) 2004-02-15
TR200400585T4 (tr) 2004-04-21
DK1166773T3 (da) 2004-06-07
AU5409201A (en) 2002-03-28
DE60101979D1 (de) 2004-03-18
AU782838B2 (en) 2005-09-01
PT1166773E (pt) 2004-05-31
CN1341591A (zh) 2002-03-27
HUP0102699A2 (en) 2002-06-29
NO330296B1 (no) 2011-03-21

Similar Documents

Publication Publication Date Title
BR9810658A (pt) Composições farmacêuticas contendo hemissulfato de eletriptano e cafeìna.
BR9809304A (pt) "formulações de proteìna c ativada"
CY1112274T1 (el) Νεοι ολιγοσακχαριτες, η παρασκευh τους και οι φαρμακευτικες συνθεσεις οι οποιες τους περιεχουν
TR199903191T2 (xx) Vorikonazol i�eren ila� form�lasyonlar�.
CY1109912T1 (el) 3-[(2z)-[1-(3,4-διμεθυλοφαινυλο)-1,5-διυδρο-3-μεθυλο-5-οξο-4η-πυραζολο-4-υλιδενο]υδραζινο-2’-υδροξυ-[1,1’-διφαινυλο]-3-καρβοξυλικο οξυ δι-(μονοαιθανολαμινικο)
CA2671383A1 (en) Dried composition
BR9902086A (pt) Formulações farmacêuticas.
AU2001289438A1 (en) Pharmaceutical semi-solid composition of isotretinoin
BR0007472A (pt) Agente contendo paramilonas, seco por congelação, sua produção e utilização
IS2148B (is) (Metýlsúlfónýl)fenýl-2-(5H)-fúranón sem COX-2 hindrar
HUP0000564A2 (hu) Olajos szuszpenzió alakú gyógyászati készítmények
MXPA03006224A (es) Inhibidores de cruzipaina y otras proteasas de cisteina.
BR0102604A (pt) Solução de sal monossódico da n-[o-(p-pivaloiloxibenzenossul-fonilamino) benzoil] glicina tetrahidratado e produto de droga do mesmo
AR035266A1 (es) Solucion desinfectante basada en hipoclorito sodico y procedimiento para su preparacion
BR9808140A (pt) Formulação unitária
TR199902703T2 (xx) Proteaz inhibit�rleri.
NZ505821A (en) Pharmaceutical compositions of uridine triphosphate
ES8600051A1 (es) Procedimiento de obtencion de composiciones farmaceuticas a base de derivados de acido glicirretinico.
DE69928279D1 (de) Lungensurfactant zubereitungen enthaltendes behandlungset
DE60106040D1 (de) Verfahren zur herstellung von dinatrium-2,2'-dithiobis(ethansulfonat)
NO993407L (no) Fremstilling av proteinpreparater med nedsatt aggregatinnhold
HU9600758D0 (en) Diclofenac composition of diminished gastrointestinal irritation and enhanced biological resorption
PT896821E (pt) Uma nova composicao farmaceutica para inalacao que contem cr 2039 (andolast)
NO306395B1 (no) Tilidindihydrogenortofosfat, fremgangsmaate for dets fremstilling og farmasöytiske preparater inneholdende forbindelsen samt anvendelser derav
WO2002056840A3 (de) Kosmetisches und/oder pharmazeutisches mittel acylierte aminosaüre enthaltend.

Legal Events

Date Code Title Description
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: PARA: INT. CL. A61K 31/22, A61K 9/19, A61K 47/02, A61K 9/08, A61P11/00

Ipc: A61K 31/22 (2010.01), A61K 9/19 (2010.01), A61K 47

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B09X Republication of the decision to grant [chapter 9.1.3 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 26/06/2012, OBSERVADAS AS CONDICOES LEGAIS.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE AS 12A, 13A E 14A ANUIDADES.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.